Hemab Therapeutics Holdings, Inc. COAG
Set alert
41.18 USD -0.27 -0.65%
At close · Nov 2
41.18 0.00 0.00%
After hours · Nov 2, 4:00 PM ET
39.96 Day range 42.91
24.98 52-week range 54.94
- YTD
- +21.12%
- 1 year
- +21.12%
- Open
- 41.67
- Prev close
- 41.45
- Mkt cap
- 1.92B
- Vol
- 343.88K
- Avg vol
- 459.12K
- EPS
- -4.31
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 39.96
- High
- 42.91
- Forward P/E
- -16.17
- Beta
- 0.00
- Short ratio
- 5.27
- Inst. own
- 92.52%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 16, 2026
- 50-d avg
- 37.90
- 200-d avg
- 36.78
- 1y target
- 62.67
MAX chart
Events in this range
- May 21, 2026Earnings: -23.98; estimate -23.245; surprise -3.16%
- Jul 13, 2026Rating: Wedbush · Outperform → Outperform
- Jul 13, 2026Rating: Jefferies · Buy → Buy
- Aug 11, 2026Earnings: -0.8; estimate -0.7325; surprise -9.22%
- Aug 11, 2026Rating: HC Wainwright & Co. · Buy → Buy
- Aug 12, 2026Rating: Wedbush · Outperform → Outperform
- Oct 12, 2026Rating: Rodman & Renshaw · — → Buy
- Oct 15, 2026Rating: JP Morgan · — → Overweight
Signals (34)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Oct 21, 2026 | 1 week ago |
| SMA: Bullish | Oct 19, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 16, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 15, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 12, 2026 | 3 weeks ago |
| MACD: Buy Signal | Oct 12, 2026 | 3 weeks ago |
| SMA: Bullish | Oct 9, 2026 | 3 weeks ago |
| RSI: Oversold | Sep 24, 2026 | 1 month ago |
| SMA: Bearish | Aug 28, 2026 | 2 months ago |
| SMA: Bullish | Aug 27, 2026 | 2 months ago |
| SMA: Bearish | Aug 26, 2026 | 2 months ago |
| SMA: Bullish | Aug 25, 2026 | 2 months ago |
| SMA: Bearish | Aug 24, 2026 | 2 months ago |
| SMA: Bullish | Aug 21, 2026 | 2 months ago |
| SMA: Bearish | Aug 20, 2026 | 2 months ago |
| SMA: Bearish | Aug 19, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 18, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 13, 2026 | 2 months ago |
| SMA: Bullish | Aug 5, 2026 | 2 months ago |
| MACD: Sell Signal | Jul 29, 2026 | 3 months ago |
Newest 20 of 34.
Analyst view
Consensus: none
Price target (mean) 62.67 +52.2% upside
Now 41.18
- Target (low)
- 58.00
- Target (mean)
- 62.67
- Target (high)
- 70.00
Ratings (0m) 6 6 buy · 0 hold · 0 sell
- Strong buy1
- Buy5
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 6
- 1 month ago 5
- 2 months ago 5
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.51529 | -0.55 – -0.41 | 0.00 | 0.0% | 0 | 0.0% | 5 |
| Next quarter | -0.56978 | -0.62 – -0.50 | 0.00 | 0.0% | 0 | 0.0% | 5 |
| Current year | -3.11 | -3.23 – -2.77 | 0.00 | 0.0% | 0 | 0.0% | 5 |
| Next year | -2.55 | -2.81 – -2.30 | -3.11 | +18.1% | 0 | 0.0% | 5 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 15, 2026 | JP Morgan | Initiated | — | Overweight |
| Oct 12, 2026 | Rodman & Renshaw | Initiated | — | Buy |
| Aug 12, 2026 | Wedbush | Maintained | Outperform | Outperform |
| Aug 11, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Jul 13, 2026 | Jefferies | Maintained | Buy | Buy |
| Jul 13, 2026 | Wedbush | Maintained | Outperform | Outperform |
| Jul 13, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Jun 26, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jun 17, 2026 | HC Wainwright & Co. | Initiated | — | Buy |
| May 26, 2026 | Wedbush | Initiated | — | Outperform |
| May 26, 2026 | Jefferies | Initiated | — | Buy |
| May 26, 2026 | Evercore ISI Group | Initiated | — | Outperform |
| May 26, 2026 | Goldman Sachs | Initiated | — | Buy |